OMERS Administration Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History

OMERS Administration Corp’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.53M	Hold	8,092	–	–	0.01%	564
2025 Q4	$1.38M	Hold	8,092	–	–	0.01%	476
2025 Q3	$1.07M	Hold	8,092	–	–	0.01%	549
2025 Q2	$859K	Sell	8,092 -5,943	-42%	-$646K	0.01%	545
2025 Q1	$1.74M	Buy	14,035 +1,643	+13%	+$214K	0.02%	426
2024 Q4	$1.53M	Sell	12,392 -6,600	-35%	-$778K	0.01%	404
2024 Q3	$2.12M	Sell	18,992 -3,400	-15%	-$373K	0.02%	378
2024 Q2	$2.39M	Buy	+22,392	New	+$2.46M	0.02%	325
2020 Q1	–	Sell	-48,200	Closed	-$7.2M	–	290
2019 Q4	$7.2M	Sell	48,200 -6,900	-13%	-$939K	0.08%	140
2019 Q3	$7.06M	Buy	55,100 +13,600	+33%	+$1.82M	0.07%	170
2019 Q2	$6M	Hold	41,500	–	–	0.06%	174
2019 Q1	$6.15M	Buy	+41,500	New	+$5.41M	0.07%	84
2014 Q2	–	Sell	-2,200	Closed	-$305K	–	412
2014 Q1	$305K	Buy	+2,200	New	+$331K	0.01%	338

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

OMERS Administration Corp's JAZZ Position: Q1 2026 in Review

OMERS Administration Corp held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 8,092 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #564.

OMERS Administration Corp first reported a position in JAZZ in Q1 2014 and has held it in 13 quarters since. The position peaked at $7.2M in Q4 2019. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

OMERS Administration Corp held 8,092 shares of Jazz Pharmaceuticals worth $1.53M as of Q1 2026.
OMERS Administration Corp left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up 0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #564 holding.
OMERS Administration Corp first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 13 quarters since.
OMERS Administration Corp's Jazz Pharmaceuticals position peaked at $7.2M in Q4 2019.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.